Single Dose of Tranexamic Acid and Blood Loss, in Elderly Patients With Hip Fracture
Status:
Unknown status
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the hypothesis that single dose of tranexamic acid
(TXA) preoperatively will lower blood loss and transfusion rate in elderly patients with hip
fractures (intertrochanteric or Subcapital), that will be treated with intramedullary nailing
and cemented hemiarthroplasty respectively. After application of inclusion and exclusion
criteria, patients will be randomized in two groups. Group 1 will include patients that
receive preoperatively single dose of TXA (15mg/kg) and Group 2 will include patients that
receive normal saline (control group).